扩张型心肌病的血管扩张剂治疗
Vasodilator therapy of dilated cardiomyopathy.
作者信息
Cohn J N
出版信息
Postgrad Med J. 1986 Jun;62(728):599-600. doi: 10.1136/pgmj.62.728.599.
Abstract
Vasoconstriction increases impedance to ventricular ejection and impairs the performance of the dilated myopathic heart. Vasodilator drug therapy by reducing vascular resistance, increasing vascular compliance and increasing vascular capacitance improves cardiac function and relieves the signs and symptoms of congestive heart failure. Earlier intervention in an attempt to alter the natural history of cardiomyopathy should be studied.
摘要
血管收缩会增加心室射血的阻力，并损害扩张型心肌病心脏的功能。血管扩张剂药物治疗通过降低血管阻力、增加血管顺应性和增加血管容量来改善心脏功能，并缓解充血性心力衰竭的体征和症状。应该研究早期干预以试图改变心肌病自然病程的情况。
相似文献
1
Vasodilator therapy of dilated cardiomyopathy.扩张型心肌病的血管扩张剂治疗
Postgrad Med J. 1986 Jun;62(728):599-600. doi: 10.1136/pgmj.62.728.599.
2
[Impedance rheography in the evaluation of vasodilation treatment of congestive cardiomyopathy].[阻抗血流图在充血性心肌病血管舒张治疗评估中的应用]
Kardiol Pol. 1986;29(8):505-14.
3
Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure.扩张型心力衰竭患者在正常充盈压下维持心输出量。
Circulation. 1986 Dec;74(6):1303-8. doi: 10.1161/01.cir.74.6.1303.
4
5
6
[Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].[洋地黄、利尿剂及血管扩张剂治疗扩张型心肌病]
Herz. 1985 Jun;10(3):138-42.
7
8
Acute hemodynamic effects of sildenafil in patients with idiopathic dilated cardiomyopathy.西地那非对特发性扩张型心肌病患者的急性血流动力学影响。
Indian Heart J. 2008 Nov-Dec;60(6):599-601.
9
10
Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.匹莫苯丹（UD-CG 115 BS）对慢性充血性心力衰竭患者的临床疗效。
J Cardiovasc Pharmacol. 1989;14 Suppl 2:S23-30.
引用本文的文献
1
Electrical plasticity and cardioprotection in myocardial ischemia--role of selective sodium channel blockers.心肌缺血中的电可塑性和心脏保护——选择性钠通道阻滞剂的作用。
Clin Cardiol. 2013 May;36(5):255-61. doi: 10.1002/clc.22113. Epub 2013 Mar 25.
2
Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.肼屈嗪在充血性心力衰竭中的临床药代动力学及治疗应用
Clin Pharmacokinet. 1989 Feb;16(2):86-9. doi: 10.2165/00003088-198916020-00003.
本文引用的文献
1
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.通过血浆激素水平评估交感神经系统和肾素-血管紧张素系统的活性及其与充血性心力衰竭血流动力学异常的关系。
Am J Cardiol. 1982 May;49(7):1659-66. doi: 10.1016/0002-9149(82)90243-0.
2
Regional blood flow response to orthostasis in patients with congestive heart failure.
J Am Coll Cardiol. 1983 Jun;1(6):1391-5. doi: 10.1016/s0735-1097(83)80041-2.
3
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.血浆去甲肾上腺素作为慢性充血性心力衰竭患者预后的一项指标。
N Engl J Med. 1984 Sep 27;311(13):819-23. doi: 10.1056/NEJM198409273111303.
4
Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.口服转换酶抑制剂卡托普利对充血性心力衰竭的急性和长期反应。
Circulation. 1980 Jul;62(1):35-41. doi: 10.1161/01.cir.62.1.35.
5
Treatment of refractory heart failure with infusion of nitroprusside.硝普钠输注治疗难治性心力衰竭。
N Engl J Med. 1974 Sep 19;291(12):587-92. doi: 10.1056/NEJM197409192911201.
6
Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance.心力衰竭的血管扩张剂治疗。阻抗对左心室功能的影响。
Circulation. 1973 Jul;48(1):5-8. doi: 10.1161/01.cir.48.1.5.
7
Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.
Circulation. 1973 Oct;48(4):684-90. doi: 10.1161/01.cir.48.4.684.
8
Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.肾素-血管紧张素系统在慢性充血性心力衰竭全身血管收缩中的作用。
Circulation. 1978 Nov;58(5):763-70. doi: 10.1161/01.cir.58.5.763.
9
Nitrate therapy for congestive heart failure.用于充血性心力衰竭的硝酸盐疗法。
JAMA. 1978 Aug 4;240(5):443-6.
Zotero 插件